The CHIRON Group Acquires HSTEC

With the acquisition, the CHIRON Group is expanding its capacities and strengthening three areas of expertise: Complete development, manufacturing and assembly of the key components, motor spindles and turning spindles, for the Group's machining centers.
The CHIRON Group Acquires HSTEC

The CHIRON Group, headquartered in Tuttlingen, Germany, is continuing to follow its global growth strategy in 2022 too, and today announced its takeover of 90 percent of the Croatian company HSTEC.

The name HSTEC stands for »high speed technique«, for system expertise in development, design and manufacture of high-speed motor spindles for challenging machining. Clamping devices for machining centers and automation solutions complete the portfolio. Furthermore, HSTEC is leading the way in spindle services and repair for in-house products and spindles from other manufacturers.

With the acquisition, the CHIRON Group is expanding its capacities and strengthening three areas of expertise: Complete development, manufacturing and assembly of the key components, motor spindles and turning spindles, for the Group’s machining centers. With HSTEC fixtures for workpiece clamping, turnkey projects can be designed even better in line with customer-specific specifications. Furthermore, the CHIRON Group is expanding its services globally to include part repair, refurbishing and optimizing of all motor spindles in existing machines.

With the new name CHIRON Croatia, the CHIRON Group has a presence in eastern Europe with another of its own companies; it can support customers better in the region and will continue to develop at the Zadar site. Over 100 employees, 25 of whom alone work in engineering, increase the number of employees in the Group globally to around 1,900.

The current CEO Mladen Šarlija has been appointed Managing Director of CHIRON Croatia. The representative offices of HSTEC in Germany, the USA and China will remain, as well representation of Balluff, Bosch Rexroth, Hofmann and Mitutoyo for the Croatian market.

HSTEC will continue as a brand, joining the ranks of the CHIRON Group brands: CHIRON, STAMA, FACTORY5, CMS, GREIDENWEIS, HSTEC.

More

Artificial Intelligence Tools Make Education Materials More Patient Friendly

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.